ELOXX PHARMACEUTICALS INC
Q3 2026 13F Holders
Symbol
ELOX
CUSIP
29014R301
Type
Equity
Class
COM NEW
Num filings
4
Total reported value, excl. options
$1.64 k
Compare 2026 Q3 to
2026 Q2
Manager
Report Date
Value ($000)
Shares
Option Type